Welcome to our dedicated page for Aveanna Healthcare Holdings SEC filings (Ticker: AVAH), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Aveanna Healthcare Holdings Inc. (AVAH) SEC filings page on Stock Titan provides access to the company’s regulatory disclosures as filed with the U.S. Securities and Exchange Commission. Aveanna, a diversified home care platform headquartered in Atlanta, Georgia with locations in 38 states, uses these filings to report material events, financing arrangements, and financial results related to its pediatric and adult home-based healthcare services.
Among the key documents available are Current Reports on Form 8-K, where Aveanna describes material definitive agreements such as amendments to its first lien credit agreement, the creation and refinancing of term loan and revolving credit facilities, and the termination of a second lien credit agreement. Other 8-K filings report underwriting agreements for secondary offerings of common stock by existing stockholders, as well as the closing of those offerings.
Aveanna also uses Form 8-K to furnish press releases announcing quarterly and year-to-date financial results, preliminary financial data, and updated guidance. These filings often discuss non-GAAP measures such as EBITDA, Adjusted EBITDA, Normalized Adjusted EBITDA, Field contribution, Field contribution margin, Adjusted net income, and Adjusted net income per diluted share, along with reconciliations to GAAP metrics. Additional 8-K items address board and governance matters, including amendments to stockholders’ agreements and changes in board composition.
On Stock Titan, users can view these AVAH filings alongside AI-powered summaries that explain the main points of each document in plain language. Real-time updates from EDGAR help surface new 8-Ks and, when filed, periodic reports such as annual reports on Form 10-K, quarterly reports on Form 10-Q, and proxy statements. The platform also highlights insider-related filings like Form 4 when available, allowing investors to review reported transactions by directors and officers in the context of Aveanna’s broader regulatory and financial disclosures.
Aveanna Healthcare Holdings senior vice president and chief accounting officer Deborah Stewart reported open-market sales of 29,815 shares of common stock over three days. The shares were automatically sold by the company’s stock plan administrator to satisfy her tax obligations on recently vested equity awards, and she continues to hold over 300,000 shares directly.
Aveanna Healthcare Holdings Chief Administrative Officer Edwin C. Reisz reported three open-market sales of common stock in mid-February 2026, totaling 162,043 shares. The transactions covered 42,057 shares at $7.6451, 59,217 shares at $7.3829, and 60,769 shares at $7.2082 per share. According to the disclosure, these shares were automatically sold to satisfy his tax obligations related to recently vested equity awards. After these sales, Reisz directly owned 1,447,057 Aveanna shares.
Aveanna Healthcare Holdings director Rodney D. Windley reported a tax-related share disposition on the company’s common stock. On the reported date, 60,217 shares at a value of $7.93 per share were withheld to cover taxes on the vesting of 2022 performance-based restricted stock units. This was not an open-market sale but a tax-withholding transaction tied to long-term incentive awards. After this withholding, Windley’s directly held ownership stood at 2,258,017 shares of Aveanna common stock.
Aveanna Healthcare Holdings, Inc. director Brent D. Layton reported an acquisition of company stock through an equity award. On 02/14/2026, he received 18,916 shares of common stock at a price of $0 per share as a grant of stock-settled restricted stock units subject to one-year cliff vesting. Following this award, he directly beneficially owned 54,258 shares of Aveanna common stock.
Aveanna Healthcare Holdings Chief Financial Officer Matthew Buckhalter reported equity awards in company stock. On February 14, 2026, he acquired 15,213 shares of common stock upon vesting of performance-based restricted stock units from the company’s 2022 long-term incentive awards and 46,875 shares upon vesting of performance-based restricted stock units from 2023 long-term incentive awards, both at a price of $0 per share.
He also received a grant of 66,205 stock-settled restricted stock units subject to three-year cliff vesting. Following these award-related acquisitions, he directly owned 565,273 shares of Aveanna Healthcare common stock.
Aveanna Healthcare Holdings director Erica Schwartz reported an equity award. On 02/14/2026, she acquired 18,916 shares of common stock through a grant of stock-settled restricted stock units at a price of $0. The units are subject to one-year cliff vesting. Following this grant, she directly holds 276,414 shares.
Shaner Jeff reported acquisition or exercise transactions in a Form 4 filing for AVAH. The filing lists transactions totaling 715,229 shares. Following the reported transactions, holdings were 2,534,235 shares.
Stewart Deborah reported acquisition or exercise transactions in a Form 4 filing for AVAH. The filing lists transactions totaling 79,099 shares. Following the reported transactions, holdings were 264,186 shares.
Cunningham Patrick A. reported acquisition or exercise transactions in a Form 4 filing for AVAH. The filing lists transactions totaling 91,797 shares. Following the reported transactions, holdings were 314,134 shares.
Windley Rodney D reported acquisition or exercise transactions in a Form 4 filing for AVAH. The filing lists transactions totaling 289,947 shares. Following the reported transactions, holdings were 2,296,796 shares.